FCM Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$3.48M Sell
33,396
-3,852
-10% -$435K 4.97% 8
2017
Q3
$5.43M Sell
37,248
-9,032
-20% -$1.23M 6.44% 5
2017
Q2
$6.01M Sell
46,280
-18,950
-29% -$2.32M 4.59% 5
2017
Q1
$8.12M Sell
65,230
-6,750
-9% -$808K 5.12% 4
2016
Q4
$8.33M Sell
71,980
-950
-1% -$106K 5.04% 5
2016
Q3
$7.62M Sell
72,930
-926
-1% -$100K 4.27% 4
2016
Q2
$7.28M Buy
73,856
+1,783
+2% +$184K 4.33% 5
2016
Q1
$7.21M Sell
72,073
-4,150
-5% -$427K 3.85% 6
2015
Q4
$9.13M Sell
76,223
-8,900
-10% -$1.03M 4.73% 5
2015
Q3
$9.21M Sell
85,123
-3,711
-4% -$461K 4.53% 4
2015
Q2
$10.3M Sell
88,834
-366
-0.4% -$41.8K 4.9% 5
2015
Q1
$10.3M Sell
89,200
-2,100
-2% -$251K 4.97% 5
2014
Q4
$10.2M Sell
91,300
-900
-1% -$94.9K 4.79% 5
2014
Q3
$8.74M Sell
92,200
-4,600
-5% -$415K 3.98% 5
2014
Q2
$8.31M Sell
96,800
-1,700
-2% -$129K 3.81% 5
2014
Q1
$6.88M Sell
98,500
-52,100
-35% -$4.13M 2.86% 5
2013
Q4
$12.7M Sell
150,600
-1,500
-1% -$119K 5.2% 4
2013
Q3
$11.7M Sell
152,100
-4,200
-3% -$294K 4.7% 4
2013
Q2
$9.14M Buy
+156,300
New +$9.41M 4.08% 3

Other funds holding CELG

FCM Investments's CELG Position: Q4 2017 in Review

FCM Investments reduced its Celgene Corp (CELG) stake by 10% in Q4 2017, selling an estimated $435K and leaving 33,396 shares worth $3.48M. The position accounts for 4.97% of the portfolio, ranked #8.

FCM Investments first reported a position in CELG in Q2 2013 and has held it in 19 quarters since. The position peaked at $12.7M in Q4 2013. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • FCM Investments held 33,396 shares of Celgene Corp worth $3.48M as of Q4 2017.
  • FCM Investments sold 3,852 Celgene Corp shares in Q4 2017, an estimated $435K.
  • Celgene Corp made up 4.97% of FCM Investments's portfolio in Q4 2017, its #8 holding.
  • FCM Investments first reported a position in Celgene Corp in Q2 2013 and has held it in 19 quarters since.
  • FCM Investments's Celgene Corp position peaked at $12.7M in Q4 2013.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on FCM Investments's 13F filing for Q4 2017, filed 17 Jan 2018.